Immune dysregulation in extranodal NK/T cell lymphomas: potential roles in pathogenesis and immunotherapy
figure
Effects and treatment applications of polymeric nanoparticles on improving platelets' storage time: a review of the literature from 2010 to 2020
figure
Twenty-year incidence trend of hematologic malignancies in the Republic of Korea: 1999–2018
figure
Blood Res 2021; 56(4): 209~353
Perspectives
Immune dysregulation in extranodal NK/T cell lymphomas: potential roles in pathogenesis and immunotherapy
Chantana Polprasert, M.D., Kitsada Wudhikarn et al.
Blood Res 2021; 56(4): 209-211  https://doi.org/10.5045/br.2021.2021123 PDF PubMed Central
Subclinical thrombotic thrombocytopenic purpura after vaccination with ChAdOx1 nCoV-19
Hee Ryeong Jang, M.D., Kyu-Hyoung Lim et al.
Blood Res 2021; 56(4): 212-214  https://doi.org/10.5045/br.2021.2021140 PDF PubMed Central
Review Articles
Effects and treatment applications of polymeric nanoparticles on improving platelets' storage time: a review of the literature from 2010 to 2020
Tahereh Zadeh Mehrizi, Sedigheh Amini Kafiabad, Peyman Eshghi
Blood Res 2021; 56(4): 215-228  https://doi.org/10.5045/br.2021.2021094 PDF PubMed Central
A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities
Zahra Nekoukar, Minoo Moghimi, Ebrahim Salehifar
Blood Res 2021; 56(4): 229-242  https://doi.org/10.5045/br.2021.2021117 PDF PubMed Central
Original Articles
Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea
Jun Ho Yi, Gyeong-Won Lee, Ji Hyun Lee et al.
Blood Res 2021; 56(4): 243-251  https://doi.org/10.5045/br.2021.2021102 PDF PubMed Central
Mutation analysis and characterisation of F9 gene in haemophilia- B population of India
Sujayendra Kulkarni, Rajat Hegde, Smita Hegde et al.
Blood Res 2021; 56(4): 252-258  https://doi.org/10.5045/br.2021.2021016 PDF PubMed Central
Clinical features and outcomes of JAK2 V617F-positive polycythemia vera and essential thrombocythemia according to the JAK2 V617F allele burden
A-Jin Lee, Sang-Gyung Kim, Jun Yeb Nam et al.
Blood Res 2021; 56(4): 259-265  https://doi.org/10.5045/br.2021.2021089 PDF PubMed Central
Outcomes of bortezomib combination chemotherapies in autologous stem cell transplantation-ineligible patients with AL amyloidosis
Joon Young Hur, Sang Eun Yoon, Darae Kim et al.
Blood Res 2021; 56(4): 266-278  https://doi.org/10.5045/br.2021.2021121 PDF PubMed Central
Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan
Mohammad Ma’koseh, Rula Amarin, Faris Tamimi et al.
Blood Res 2021; 56(4): 279-284  https://doi.org/10.5045/br.2021.2021116 PDF PubMed Central
R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience
Ji Yun Lee, Jin Ho Paik, Koung Jin Suh et al.
Blood Res 2021; 56(4): 285-292  https://doi.org/10.5045/br.2021.2021073 PDF PubMed Central
The demographic, clinical, and medical manifestations of pulmonary thromboembolism development in COVID-19
Somayeh Sadeghi, Maryam Nasirian, Elaheh Keivany et al.
Blood Res 2021; 56(4): 293-300  https://doi.org/10.5045/br.2021.2021131 PDF PubMed Central
Original Articles
Twenty-year incidence trend of hematologic malignancies in the Republic of Korea: 1999–2018
Won-Ju Park, Joo-heon Park, Seunghyeon Cho et al.
Blood Res 2021; 56(4): 301-314  https://doi.org/10.5045/br.2021.2021187 PDF PubMed Central
Blood management strategies in congenital Glanzmann thrombasthenia at a hematology referral center
Ganesh Kasinathan, Jameela Sathar
Blood Res 2021; 56(4): 315-321  https://doi.org/10.5045/br.2021.2021165 PDF PubMed Central
Real-life ruxolitinib experience in intermediate-risk myelofibrosis
Fatma Arikan, Tayfur Toptas, Isik Kaygusuz Atagunduz et al.
Blood Res 2021; 56(4): 322-331  https://doi.org/10.5045/br.2021.2021101 PDF PubMed Central
Letters to the Editor
Shared molecular basis, diagnosis, and co-inheritance of alpha and beta thalassemia
Govinda Khatri, Abdul Moiz Sahito, Saboor Ahmed Ansari
Blood Res 2021; 56(4): 332-333  https://doi.org/10.5045/br.2021.2021128 PDF PubMed Central
Tp53 disruptions: is there a marker of poor prognosis in chronic lymphoproliferative disorders?
Emanuele Cencini, Alberto Fabbri, Donatella Raspadori et al.
Blood Res 2021; 56(4): 333-334  https://doi.org/10.5045/br.2021.2020322 PDF PubMed Central
A look inside the body of a BCR-ABL1−like acute lymphoblastic leukemia patient: the first case report highlighting the continued relevance of autopsy practice
Pulkit Rastogi, Prateek Bhatia, Sreejesh Sreedharanunni et al.
Blood Res 2021; 56(4): 335-339  https://doi.org/10.5045/br.2021.2020231 PDF PubMed Central
Therapy-related acute myeloid leukemia in a patient with B-cell acute lymphoblastic leukemia
Smeeta Gajendra, Akshay Ramesh Gore, Bhawna Jha et al.
Blood Res 2021; 56(4): 339-342  https://doi.org/10.5045/br.2021.2021093 PDF PubMed Central
Efficacy of ponatinib prior to and after allogeneic hematopoietic stem cell transplantation in an adolescent with chronic myeloid leukemia in blast phase
Jae Wook Lee, Jae Won Yoo, Seongkoo Kim et al.
Blood Res 2021; 56(4): 342-345  https://doi.org/10.5045/br.2021.2021104 PDF PubMed Central
A case of e1a2 (minor, P190) BCR-ABL1-positive chronic myeloid leukemia in Korea
Yu Jeong Choi, Ja Yoon Heo, Jongha Yoo
Blood Res 2021; 56(4): 345-347  https://doi.org/10.5045/br.2021.2020331 PDF PubMed Central
Immune thrombocytopenic purpura worsened by COVID-19
Chul Soo Kim, Dae Ro Choi, Jong Hwa Lee
Blood Res 2021; 56(4): 347-349  https://doi.org/10.5045/br.2021.2021147 PDF PubMed Central
Therapy-related myeloid neoplasms after transcatheter arterial chemoembolization for hepatocellular carcinoma
Jun Ho Yi, Jun Ho Jang, Chul Won Jung
Blood Res 2021; 56(4): 349-353  https://doi.org/10.5045/br.2021.2021197 PDF PubMed Central

Current Issue

31 December 2021 Volume 56.
Number 4 pp. 209~353
ba_link01

SCImago Journal & Country Rank

Today : 305  /
Total : 389,830